Adebelizumab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Adebelizumab, covering 2025-01-10 to 2025-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer [Phase 2]